In the context of ongoing improvements to social coverage, the National Fund for Social Insurance of Wage Earners (CNAS) has announced new measures aimed at providing additional benefits to individuals suffering from chronic diseases. This initiative is designed to alleviate the financial and administrative burden on patients while ensuring they have better access to medical care.
According to the CNAS announcement, the organization covers a total of 26 chronic diseases, as outlined in Articles 5 and 21 of Decree No. 84-27 dated February 11, 1984.
The detailed list of eligible conditions for full reimbursement is extensive and encompasses a wide range of critical medical issues. Among these targeted conditions are significant categories such as tuberculosis in all its forms, serious neurological diseases, cancerous diseases, and blood disorders.
Cardiovascular diseases, a major public health concern, are also included in this initiative. Conditions such as malignant hypertension, coronary artery diseases (including angina and myocardial infarction), strokes, and even valve replacement with a prosthesis are now fully covered.
The neurological and muscular conditions are also well represented, including diseases such as multiple sclerosis, temporal lobe epilepsy, and nerve inflammation. Rare diseases like myasthenia gravis and progressive spinal muscular atrophy are also included in the coverage.
CNAS: Detailed List of 26 Conditions Eligible for 100% Reimbursement
For complete clarity, here’s the comprehensive list of diseases that qualify for full compensation by the CNAS:
- Tuberculosis in all its forms
- Severe neurological diseases
- Cancerous diseases
- Blood disorders
- Sarcoidosis
- Malignant hypertension
- Angina
- Myocardial infarction (heart necrosis)
- Coroid artery path deviation
- Valve replacement with a prosthesis
- Advanced valve diseases
- Advanced atherosclerosis
- Diseases of the lower limb arteries
- Stroke (brain thrombosis), meningitis, or meningoencephalitis
- Heart rhythm disorders and implantation of a cardiac rhythm control device
- Multiple sclerosis
- Extrapyramidal syndromes
- Facial paralysis due to a cerebral injury
- Epilepsy (temporal lobe)
- Nerve inflammation
- Progressive spinal muscular atrophy
- Myopathy (muscle atrophy)
- Myasthenia gravis
- Cerebral injury
- Kidney diseases
- Ankylosing spondylitis
- Rheumatoid arthritis
- Acute osteoporosis
- Rheumatoid nodular polyarthritis
- Disseminated lupus erythematosus
- Chronic respiratory failure due to obstruction
- Acute poliomyelitis
- Diabetes
- Hyperproteinemia
- Hyperlipidemia
- Congenital heart defects
- Endocrine gland disorders
- Acute rheumatoid polyarthritis
- Chronic inflammation of bones and joints
- Severe and lasting complications from ulcers and infectious resections
- Liver cirrhosis
- Hemorrhagic inflammatory colitis
- Malignant and psoriatic pemphigoid
- Leprosy and its complications
Chronic Diseases: What Concrete Advantages for Policyholders?
Individuals diagnosed with one of these conditions can now take advantage of several significant improvements:
- The enhancement of the reimbursement rate for natural benefits to 100% of the reference tariffs set by the applicable regulations.
- Exemption from the limitation on the number of prescriptions covered under the third-party payment system, capped at two prescriptions every three (03) months.
- Exemption from the limit on the amount of the medical prescription, which is set at 5,000 DA.
- Coverage for daily allowances at 100% starting from the first day of work cessation, for a maximum of three (03) years for employees who must stop working due to a long-term condition.
How to Benefit from These Rights?
To take advantage of these rights, policyholders (or their dependents) must visit their respective CNAS agency, bringing the following documents:
- A medical certificate confirming the diagnosis.
- All medical exams and reports verifying the disease.
General News – 2